• Imaging agents

Xenoview Generic Name & Formulations

General Description

Xenon Xe 129 hyperpolarized; gas for oral inh.

Pharmacological Class

Hyperpolarized contrast agent.

How Supplied

Dose Delivery Bag (1000mL)—50 (w. attachable mouthpieces and affixable dose labels) 


Generic Availability


Xenoview Indications


For use with MRI for evaluation of lung ventilation in adults and pediatric patients.

Limitations of Use

Not for use with lung perfusion imaging.

Xenoview Dosage and Administration


See full labeling. Measure volume and Dose Equivalent (DE) in the dose delivery bag using the HPX Polarization Measurement Station no more than 5mins prior to administration. Inhale the full dose and hold for up to 15secs during MR image acquisition; may repeat with a new dose if image quality is insufficient. ≥12yrs: 75–100mL DE of the entire contents of 1 dose delivery bag; DE of >100mL is acceptable. DE = (total volume xenon gas [250–750mL]) x (fraction of xenon Xe 129 isotopic enrichment in the xenon gas [>80%]) x (fraction of hyperpolarization [mean fraction 38–54% at the completion of polarization of 250mL of xenon gas]). 


<12yrs: not indicated.

Xenoview Contraindications

Not Applicable

Xenoview Boxed Warnings

Not Applicable

Xenoview Warnings/Precautions


Risk of decreased image quality from supplemental oxygen. Transient hypoxia. Monitor all patients for oxygen desaturation and symptoms of hypoxemia; treat as clinically indicated. Pregnancy. Nursing mothers.

Xenoview Pharmacokinetics


Half-life: 14.5 seconds for a 75% Xe/25% N2 gas mixture; 14.3 seconds for a 25% Xe/75% N2 gas mixture. 

Xenoview Interactions

Xenoview Adverse Reactions

Adverse Reactions

Oropharyngeal pain, headache, dizziness.

Xenoview Clinical Trials

See Literature

Xenoview Note

Not Applicable

Xenoview Patient Counseling

See Literature